Indaptus Therapeutics, Inc.
INDP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $5,787 | $13,362 | $9,627 | $39,132 |
| Short-Term Investments | $0 | $0 | $16,806 | $0 |
| Receivables | $0 | $0 | $0 | $21 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $832 | $633 | $811 | $1,234 |
| Total Curr. Assets | $6,618 | $13,995 | $27,244 | $40,387 |
| Property Plant & Equip (Net) | $82 | $174 | $81 | $173 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $638 | $755 | $738 | $16 |
| Total NC Assets | $720 | $929 | $820 | $189 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $7,339 | $14,924 | $28,064 | $40,577 |
| Liabilities | – | – | – | – |
| Payables | $870 | $806 | $1,378 | $2,638 |
| Short-Term Debt | $84 | $102 | $80 | $96 |
| Tax Payable | $0 | $40 | $129 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $2,439 | $1,826 | $1,846 | $1,870 |
| Total Curr. Liab. | $3,394 | $2,774 | $3,433 | $4,604 |
| LT Debt | $0 | $73 | $0 | $73 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $73 | $0 | $73 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $84 | $175 | $80 | $169 |
| Total Liabilities | $3,394 | $2,847 | $3,433 | $4,677 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $120 | $84 | $84 | $83 |
| Retained Earnings | -$60,439 | -$45,417 | -$29,994 | -$15,671 |
| AOCI | $0 | $0 | $96 | $0 |
| Other Equity | $64,264 | $57,410 | $54,444 | $51,488 |
| Total Equity | $3,945 | $12,076 | $24,630 | $35,900 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $7,339 | $14,924 | $28,064 | $40,577 |
| Net Debt | -$5,703 | -$13,187 | -$9,546 | -$38,963 |